Core Scientific, Inc. Form 8-K Summary
Business Context and Reporting Period
Core Scientific, Inc. filed this Form 8-K on March 25, 2022 under Item 7.01, Regulation FD Disclosure. The filing announces the planned release of the company’s full fiscal year 2021 financial results.
Financial Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial results. The fiscal year 2021 results were scheduled for release after the market closed on March 29, 2022.
Material Changes Versus the Prior Comparable Period
The filing does not disclose financial or operating changes versus the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
- Management scheduled an investor conference call and live audio webcast for March 29, 2022, at 4:30 p.m. Eastern Time to discuss fiscal year 2021 results.
- Participation instructions were included in Exhibit 99.1, the March 25, 2022 press release.
- No guidance, outlook, risk factors, contingencies, or unusual items are disclosed in the filing text.
- The information was furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act.
Important Facts for Investors to Verify
- Obtain the company’s fiscal year 2021 results released on March 29, 2022.
- Review the accompanying earnings presentation and conference call commentary for operating performance, liquidity, financing, and outlook.
- Confirm the details in Exhibit 99.1, including the webcast and conference call access instructions.
- Note that Core Scientific’s common stock traded under CORZ and its warrants under CORZW on Nasdaq as of the filing date.